Boots purchases Lutsia

Fallon, James
September 1996
WWD: Women's Wear Daily;9/27/1996, Vol. 172 Issue 61, p9
Trade Publication
Reports on British beauty retailer Boots Co. PLC's acquisition of Laboratoires Lutsia of France. Expansion of skin care operations with the purchase; Plans to use the acquisition as a vehicle to turn Boots Healthcare International unit into a leader in the development, manufacture and marketing of over-the-counter skin medication.


Related Articles

  • Boots looks east. Fallon, James // WWD: Women's Wear Daily;12/2/1996, Vol. 172 Issue 103, p8 

    Reports on the expansion plans of London-based beauty retailer Boots Co. PLC in Europe and Asia. Opening of a branch in Ireland; Plans of opening shops in Japan, Thailand and the Netherlands; Cooperation with local retailers; Company facts.

  • Boots revamps Wellbeing in customer appeal revamp. Francis, Ollie // Precision Marketing;9/6/2002, Vol. 14 Issue 49, p3 

    Reports the renovation of Internet site by Boots in Great Britain. Purpose for the renovation of the site; Analysis on the effectiveness of the site by Site Intelligence; Statement on the site renovation by chief operating officer Mark Dearnley.

  • Boots opts for chp.  // Modern Power Systems;Mar96, Vol. 16 Issue 3, p11 

    Reports on Boots' plans to build a combined heat and power plant at its site at Beeston, Great Britain. Plant description.

  • Boots pulls CHF drug from pharmacy shelves. Starr, Cynthia // Drug Topics;8/16/93, Vol. 137 Issue 16, p76 

    Reports on Boots Pharmaceuticals Inc.'s recall of the drug flosequinan or Manoplax. Association with symptoms of congestive heart failure; Increased risk of mortality; Prospective Randomized Flosequinan Longevity Evaluation (PROFILE); Drug's availability on compassionate-use only basis;...

  • Boots set to go globe-trotting. Fallon, James // WWD: Women's Wear Daily;12/3/1993, Vol. 166 Issue 107, p7 

    Focuses on the Boots Co.'s global expansion plans. Marketing of private label natural cosmetics products; Dominance of beauty product marketing in the United Kingdom; Appointment of distributors in Switzerland, Austria and Germany.

  • Drug company `suppressed' publication of research. Wadman, Meredith // Nature;5/2/1996, Vol. 381 Issue 6577, p4 

    Reports on the implications of Boots Co. PLC's decision to suppress the publication of a journal article out of fear that the study's conclusions would hurt the company sales of one of its products, a thyroid drug. Results of the comparative study of Synthroid, the company's drug, and three...

  • Boots.  // Marketing (00253650);8/1/2002, p11 

    Features Boots, a largest drugstore chain in Great Britain. Company operations; Management schemes; Promotional and advertising efforts.

  • Heartbreak for Boots as Manoplax fails. Chynoweth, Emma // Chemical Week;7/28/1993, Vol. 153 Issue 3, p12 

    Speculates on the sale or closure of Nottingham, England-based Boot's prescription drug business. Company's withdrawal of congestive heart failure drug Manoplax from the market; Reason for the withdrawal; Analysts' estimates of amount to be generated by the sale.

  • Boots and the environment. Stuart, Greg // Housewares;Jun93, Issue 99, p12 

    Looks at the environmental policy development of Great Britain's Boots. Strategy; Implementation of reduce, re-use and recycle policy through line managers; `Green Teams'; Membership in environmental associations; Energy policy in 1975; Boots `World' symbol for environmental labelling; Plastic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics